Quillivant XR 25 MG/5 ML susp 60ML
Ended Awarded
- Contract number
- SPE2DB25FZGQ8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,974
Award facts
- Contract value 100% obligated
- $3,973.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Quillivant XR 25 mg/5 mL suspension in 60 mL quantities, with a ceiling value of $3,973.81 and a firm fixed price structure. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract is scheduled for ultimate completion on September 17, 2025.
Quillivant XR is a brand-name psychostimulant medication primarily prescribed for attention-deficit/hyperactivity disorder (ADHD) treatment. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order exemplifies the company's role in fulfilling federal medical supply needs across multiple therapeutic domains, leveraging its expansive IDC vehicle to deliver specialized medications to the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FZGQ8?
SPE2DB25FZGQ8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FZGQ8 worth?
The government has obligated $3,974 on SPE2DB25FZGQ8.
Is contract SPE2DB25FZGQ8 an order under another contract?
Yes. SPE2DB25FZGQ8 is a delivery order under SPE2DB24D1107, an indefinite delivery contract.
Was contract SPE2DB25FZGQ8 competed?
The extent of competition for SPE2DB25FZGQ8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award